Ultrastructural Localization of Platelet Endothelial Cell Adhesion Molecule (PECAM-1, CD31) in Vascular Endothelium

Journal of Histochemistry and Cytochemistry

Volumn 52, Issue 1, 2004, Pages 87-101

  Feng, Dian ^a   Nagy, Janice A ^a   Pyne, Kathryn ^a   Dvorak, Harold F ^a   Dvorak, Ann M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CD31; Electron microscopy; Endothelial cells; Nanogold immunocytochemistry; PECAM 1; VEGF A; VVOs

Indexed keywords

ANTIBODY; CD31 ANTIGEN; VASCULOTROPIN A;

ACCURACY; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL JUNCTION; CELL MEMBRANE; CELL ORGANELLE; CELL ULTRASTRUCTURE; CELL VACUOLE; ENDOTHELIUM CELL; FEMALE; IMMUNOGOLD ELECTRON MICROSCOPY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TUMOR; VASCULAR ENDOTHELIUM; VESICULOVACUOLAR ORGANELLE;

ANIMALIA; MURINAE;

EID: 0348048876     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215540405200109     Document Type: Article

References (61)

1. Albelda SM, Muller WA, Buck CA, Newman PJ (1991) Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule. J Cell Biol 114:1059-1068
2. Albelda SM, Oliver PD, Romer LH, Buck CA (1990) EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol 110:1227-1237
3. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B (1994) Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 126:247-258
4. Baldwin HS, Shen HM, Yan HC, DeLisser HM, Chung A, Mickahin C, Trask T, et al. (1994) Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 120:2539-2553
5. Bogen SA, Baldwin HS, Watkins SC, Albelda SM, Abbas AK (1992) Association of murine CD31 with transmigrating lymphocytes following antigenic stimulation. Am J Pathol 141:843-854
6. Cao G, O'Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM (2002) Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol 282:C1181-1190
7. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101
8. Christofidou-Solomidou M, Nakada MT, Williams J, Muller WA, DeLisser HM (1997) Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol 158:4872-4878
9. Cicmil M, Thomas JM, Leduc M, Bon C, Gibbins JM (2002) Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Blood 99:137-144
10. DeLisser HM, Chilkotowsky J, Yan HC, Daise ML, Buck CA, Albelda SM (1994) Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties. J Cell Biol 124:195-203
11. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, et al. (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677
12. Dvorak AM, Kohn S, Morgan ES, Fox P, Nagy JA, Dvorak HF (1996) The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J Leukocyte Biol 59:100-115
13. Ebata N, Sawa Y, Nodasaka Y, Yamaoka Y, Yoshida S, Totsuka Y (2001) Immunoelectron microscopic study of PECAM-1 expression on lymphatic endothelium of the human tongue. Tissue Cell 33:211-218
14. Erhard H, Rieweld FJ, Brocker EB, de Waal RM, Ruiter DJ (1996) Phenotype of normal cutaneous microvasculature. Immunoelectron microscopic observations with emphasis on the differences between blood vessels and lymphatics. J Invest Dermatol 106:135-140
15. Famiglietti J, Sun J, DeLisser HM, Albelda SM (1997) Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity. J Cell Biol 138:1425-1435
16. Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K, Mulligan R, et al. (2000a) Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 48:545-556
17. Feng D, Nagy JA, Dvorak AM, Dvorak HF (2000b) Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. Microvasc Res 59:24-37
18. Feng D, Nagy J, Dvorak H, Dvorak A (2002) Ultrastructural studies define soluble macromolecular, particulate, and cellular transendothelial cell pathways in venules, lymphatic vessels, and tumor-associated microvessels in man and animals. Microsc Res Tech 57:289-326
19. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM (1996) Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin. J Exp Med 183:1981-1986
20. Feng D, Nagy JA, Hipp J, Pyne K, Dvorak HF, Dvorak AM (1997) Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea-pig, mouse and rat: many are transcellular pores. J Physiol 504(pt 3):747-761
21. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM (1998) Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 187:903-915
22. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM (1999) Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators. Microcirculation 6:23-44
23. Graesser D, Solowiej A, Bruckner M, Osterweil E, Juedes A, Davis S, Ruddle NH, et al. (2002) Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J Clin Invest 109:383-392
24. Grafe M, Auch-Schwelk W, Graf K, Terbeek D, Hertel H, Unkelbach M, Hildebrandt A, et al. (1994) Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts. Am J Physiol 267:H2138-2148
25. Henshall TL, Jones KL, Wilkinson R, Jackson DE (2001) Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J Immunol 166:3098-3106
26. Ilan N, Mohsenin A, Cheung L, Madri JA (2001) PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 15:362-372
27. Ioffreda MD, Albelda SM, Elder DE, Radu A, Leventhal LC, Zweiman B, Murphy GF (1993) TNFa induces E-selectin expression and PECAM-1 (CD31) redistribution in extracutaneous tissues. Endothelium 1:47-54
28. Jackson DE (2003) The unfolding tale of PECAM-1. FEBS Lett 540:7-14
29. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, et al. (1992) A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118:1511-1522
30. Liao F, Huynh HK, Eiroa A, Greene T, Polizzi E, Muller WA (1995) Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 182:1337-1343
31. Liao F, Schenkel AR, Muller WA (1999) Transgenic mice expressing different levels of soluble platelet/endothelial cell adhesion molecule-IgG display distinct inflammatory phenotypes. J Immunol 163:5640-5648
32. Lossinsky AS, Wisniewski HM (1998) Immunoultrastructural expression of ICAM-1 and PECAM-1 occurs prior to structural maturity of the murine blood-brain barrier. Dev Neurosci 20:518-524
33. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA (2003) Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 421:748-753
34. Marszalek A, Daa T, Kashima K, Nakayama I, Yokoyama S (2000) Ultrastructural and morphometric studies related to expression of the cell adhesion molecule PECAM-1/CD31 in developing rat lung. J Histochem Cytochem 48:1283-1289
35. Metzelaar MJ, Korteweg J, Sixma JJ, Nieuwenhuis HK (1991) Biochemical characterization of PECAM-1 (CD31 antigen) on human platelets. Thromb Haemost 66:700-707
36. Muller WA (1995a) The role of PECAM-1 (CD31) in leukocyte emigration: studies in vitro and in vivo. J Leukocyte Biol 57:523-528
37. Muller WA (1995b) The use of anti-PECAM reagents in the control of inflammation. Agents Actions Suppl 46:147-157
38. Muller WA, Randolph GJ (1999) Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukocyte Biol 66:698-704
39. Muller WA, Ratti CM, McDonnell SL, Cohn ZA (1989) A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170:399-414
40. Muller WA, Weigl SA, Deng X, Phillips DM (1993) PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-460
41. Murohara T, Delyani JA, Albelda SM, Lefer AM (1996) Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 156:3550-3557
42. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Manseau EJ, Dvorak AM, et al. (2002) VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. In Cold Spring Harbor Symposia on Quantitative Biology. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press
43. Newman PJ (1994) The role of PECAM-1 in vascular cell biology. Ann NY Acad Sci 714:165-174
44. Newman PJ (1997) The biology of PECAM-1. J Clin Invest 100:S25-29
45. Newman DK, Hamilton C, Newman PJ (2001) Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 97:2351-2357
46. Newman PJ, Hillery CA, Albrecht R, Parise LV, Berndt MC, Mazurov AV, Dunlop LC, et al. (1992) Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol 119:239-246
47. Newman PJ, Newman DK (2003) Signal transduction pathways mediated by PECAM-1. New roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol 23:953-964.
48. Newton-Nash DK, Newman PJ (1999) A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 163:682-688
49. O'Brien CD, Lim P, Sun J, Albelda SM (2003) PECAM-1-dependent neutrophil transmigration is independent of monolayer PECAM-1 signaling or localization. Blood 101:2816-2825
50. Ohto H, Maeda H, Shibata Y, Chen RF, Ozaki Y, Higashihara M, Takeuchi A, et al. (1985) A novel leukocyte differentiation antigen: two monoclonal antibodies TM2 and TM3 define a 120-kd molecule present on neutrophils, monocytes, platelets, and activated lymphoblasts. Blood 66:873-881
51. Pettersson A, Nagy JA, Brown LF, Sundberg C, Morgan E, Jungles S, Carter R, et al. (2000) Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80:99-115
52. Rival Y, Del Maschio A, Rabiet MJ, Dejana E, Duperray A (1996) Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-alpha and IFN-gamma. J Immunol 157:1233-1241
53. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K (1998) Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 46:165-176
54. Schimmenti LA, Yan HC, Madri JA, Albelda SM (1992) Platelet endothelial cell adhesion molecule, PECAM-1, modulates cell migration. J Cell Physiol 153:417-428
55. Scholz D, Schaper J (1997) Platelet/endothelial cell adhesion molecule-1 (PECAM-1) is localized over the entire plasma membrane of endothelial cells. Cell Tissue Res 290:623-631
56. Sheibani N, Sorenson CM, Frazier WA (1999) Tissue specific expression of alternatively spliced murine PECAM-1 isoforms. Dev Dyn 214:44-54
57. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML, Ward PA, et al. (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262:1580-1582
58. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, et al. (1994) Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 63:247-254
59. Yan HC, Baldwin HS, Sun J, Buck CA, Albelda SM, DeLisser HM (1995) Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem 270:23672-23680
60. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM (1999) Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 3:181-188
61. Zocchi MR, Ferrero E, Leone BE, Rovere P, Bianchi E, Toninelli E, Pardi R (1996) CD31/PECAM-1-driven chemokine-independent transmigration of human T lymphocytes. Eur J Immunol 26:759-767